Clinical Applications of Advanced Ophthalmic Imaging
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-99
SponsorUniversity of Miami
About this trial
The purpose of this study is to determine the clinical application of advanced ophthalmic imaging devices such as optical coherence tomography (OCT), retinal function imager (RFI), slit-lamp biomicroscopy (SLB), PERG in diseased eyes and normal controls.
There are two phases in this study. The first phase is an observational phase which studies the eye in various conditions. The second phase is an interventional phase which studies the changes in the eyes after taking an over-the-counter medical food (Ocufolin) for 6 months.
Eligibility criteria
Qualifiers
Self-reported normal healthy subjects;
Clinical diagnosis of Alzheimer's Disease, mild cognitive impairment, multiple sclerosis, dry eye, myopia, diabetics and stroke;
Who can keep the eye open for imaging.
Disqualifiers
who can not read and sign the ICF;
who can not receiving ophthalmic imaging;
who cannot tolerate bright light during imaging.
Is at least 18 years old and has full legal capacity to volunteer;
Trial design
Treatments tested in this trial
- Ocufolin
Treatment groups
5,000 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov